---
figid: PMC3513217__pgpm-4-011f3
figlink: /pmc/articles/PMC3513217/figure/f3-pgpm-4-011/
number: Figure 3
caption: 'Metabolism pathway of tamoxifen and its interaction with estrogen receptors.Copyright
  © 2009. Nature Publishing Group. Adapted and reprinted with permission; Hoskins
  JM, Carey LA, McLeod HL. CYP2D6 and tamoxifen: DNA matters in breast cancer. Nat
  Rev Cancer 2009;9:576–586.Abbreviations: CYP, cytochrome P450; ER, estrogen receptor;
  FMO, flavin-containing monooxygenases; SULT1A1, sulphotransferase 1A1; UGT, uridine
  diphosphate glucuronosyltransferase.'
pmcid: PMC3513217
papertitle: 'Pharmacogenomics of drug metabolizing enzymes and transporters: implications
  for cancer therapy.'
reftext: Jing Li, et al. Pharmgenomics Pers Med. 2011;4:11-33.
pmc_ranked_result_index: '18026'
pathway_score: 0.9691947
filename: pgpm-4-011f3.jpg
figtitle: Metabolism pathway of tamoxifen and its interaction with estrogen receptors.Copyright
  © 2009
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3513217__pgpm-4-011f3.html
  '@type': Dataset
  description: 'Metabolism pathway of tamoxifen and its interaction with estrogen
    receptors.Copyright © 2009. Nature Publishing Group. Adapted and reprinted with
    permission; Hoskins JM, Carey LA, McLeod HL. CYP2D6 and tamoxifen: DNA matters
    in breast cancer. Nat Rev Cancer 2009;9:576–586.Abbreviations: CYP, cytochrome
    P450; ER, estrogen receptor; FMO, flavin-containing monooxygenases; SULT1A1, sulphotransferase
    1A1; UGT, uridine diphosphate glucuronosyltransferase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYP2C9
  - CYP2C19
  - CYP2B6
  - CYP2D6
  - FMO1
  - CYP1A2
  - FMO3
  - ESR1
  - SULT1A1
  - CYP3A4
  - CYP3A5
  - 4-Hydroxytamoxifen
  - N-desmethyltamoxifen
  - Tamoxifen N-oxide
  - Endoxifen
  - Estrogen
  - Tamoxifen
  - Glucuronide
genes:
- word: CYP2C9
  symbol: CYP2C9
  source: hgnc_symbol
  hgnc_symbol: CYP2C9
  entrez: '1559'
- word: CYP2C19
  symbol: CYP2C19
  source: hgnc_symbol
  hgnc_symbol: CYP2C19
  entrez: '1557'
- word: CYP2B6
  symbol: CYP2B6
  source: hgnc_symbol
  hgnc_symbol: CYP2B6
  entrez: '1555'
- word: CYP2D6
  symbol: CYP2D6
  source: hgnc_symbol
  hgnc_symbol: CYP2D6
  entrez: '1565'
- word: FMO1
  symbol: FMO1
  source: hgnc_symbol
  hgnc_symbol: FMO1
  entrez: '2326'
- word: CYP1A2
  symbol: CYP1A2
  source: hgnc_symbol
  hgnc_symbol: CYP1A2
  entrez: '1544'
- word: FMO3
  symbol: FMO3
  source: hgnc_symbol
  hgnc_symbol: FMO3
  entrez: '2328'
- word: ERa)
  symbol: ER-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: ESR1
  entrez: '2099'
- word: SULT1A1
  symbol: SULT1A1
  source: hgnc_symbol
  hgnc_symbol: SULT1A1
  entrez: '6817'
- word: CYP3A4
  symbol: CYP3A4
  source: hgnc_symbol
  hgnc_symbol: CYP3A4
  entrez: '1576'
- word: CYP3A5
  symbol: CYP3A5
  source: hgnc_symbol
  hgnc_symbol: CYP3A5
  entrez: '1577'
chemicals:
- word: 4-Hydroxytamoxifen
  source: MESH
  identifier: C016601
- word: N-desmethyltamoxifen
  source: MESH
  identifier: C028787
- word: Tamoxifen N-oxide
  source: MESH
  identifier: C035830
- word: Endoxifen
  source: MESH
  identifier: C055492
- word: Estrogen
  source: MESH
  identifier: D004967
- word: Tamoxifen
  source: MESH
  identifier: D013629
- word: Glucuronide
  source: MESH
  identifier: D020719
diseases: []
---
